Effect of Age, Comedications, and CYP3A4/5 Polymorphisms on Perampanel Exposure in Chinese Pediatric Patients With Epilepsy
The Journal of Clinical Pharmacology · 2024
DOI: 10.1002/jcph.2415 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, 2024. Verfasst von Huijuan Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, Ch…. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP3A, Epilepsy, Anticonvulsants, Pyridones. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Key R&D Program of China, Special Research Foundation of the Zhejiang Pharmaceutical Association, Open Program of Key Laboratory of Intelligent Pharmacy and Individualized Therapy of Huzhou & Changxing Anti-cancer Association.
Abstract (Originalsprache)
Perampanel (PER) is a new type of antiseizure medication used for partial or generalized seizures. However, the plasma concentration shows obvious individual variability in children. The present study aims to ascertain the effect of age, comedications, and cytochrome P450 (CYP) 3A4/5 polymorphisms on PER exposure in Chinese pediatric patients with epilepsy. Clinical data were retrospectively collected in a tertiary children's hospital medical records system from January 2021 to December 2022. The influence factors on the daily dose, plasma concentration, and concentration‐to‐dose ratio (CDR) of PER were investigated. A total of 135 pediatric patients with 178 blood samples were involved. With a median daily dose of 4.0 mg (interquartile range, 3.0‐5.0 mg), the median plasma concentration was 409.4 ng/mL (interquartile range, 251.7‐639.4 ng/mL). The CDR in patients aged less than 4 years was significantly decreased by 48.0% and 39.1% compared with those aged 4‐11 years and 12 years or older, respectively. Enzyme inducers significantly decreased the CDR of PER by 34.5%, while valproic acid showed an increase of 71.7%. In addition, genotype CYP3A5*3/*3 carriers presented a significant increase of 21.5% compared to the CYP3A5*1/*3 expresser. No correlations were observed between the CDR and CYP3A4∗1G polymorphism. PER showed high variations in individual plasma concentrations. Age younger than 4 years, comedication with enzyme inducers or valproic acid, and possession of the CYP3A5*3 genotype potentially predicted PER exposure in pediatric patients with epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
- Research Center for Clinical Pharmacy, Zhejiang University, Hangzhou, China.
- Department of Pharmacy, Changxing People's Hospital; Changxing Branch, Second Affiliated Hospital of Zhejiang University School of Medicine, Huzhou, China.
- Key Laboratory of Intelligent Pharmacy and Individualized Therapy of Huzhou, Huzhou, China.
Förderung
- National Key R&D Program of China
- Special Research Foundation of the Zhejiang Pharmaceutical Association
- Open Program of Key Laboratory of Intelligent Pharmacy and Individualized Therapy of Huzhou & Changxing Anti-cancer Association
- National Basic Research Program of China
Zitieren
APA
Wang, H., Wang, J., Lin, B., Zhang, H., Sun, Y., Wu, Y., Ye, W., & Miao, J. (2024). Effect of Age, Comedications, and CYP3A4/5 Polymorphisms on Perampanel Exposure in Chinese Pediatric Patients With Epilepsy. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.2415
Vancouver
Wang H, Wang J, Lin B, Zhang H, Sun Y, Wu Y, et al. Effect of Age, Comedications, and CYP3A4/5 Polymorphisms on Perampanel Exposure in Chinese Pediatric Patients With Epilepsy. The Journal of Clinical Pharmacology. 2024. doi:10.1002/jcph.2415
BibTeX
@article{Wang2024,
author = {Wang, Huijuan and Wang, Junyan and Lin, Bin and Zhang, Huifen and Sun, Yangyang and Wu, Yuanyuan and Ye, Weifeng and Miao, Jing},
title = {Effect of Age, Comedications, and CYP3A4/5 Polymorphisms on Perampanel Exposure in Chinese Pediatric Patients With Epilepsy},
journal = {The Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1002/jcph.2415}
}
EUVIMED